> top > docs > PMC:7546122 > spans > 4253-4557 > annotations

PMC:7546122 / 4253-4557 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T18 37-43 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970
T19 110-115 Body_part denotes blood http://purl.org/sig/ont/fma/fma9670
T20 292-294 Body_part denotes AG http://purl.org/sig/ont/fma/fma61898

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 110-115 Body_part denotes blood http://purl.obolibrary.org/obo/UBERON_0000178

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T37 37-43 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T38 110-115 http://purl.obolibrary.org/obo/UBERON_0000178 denotes blood
T39 110-115 http://www.ebi.ac.uk/efo/EFO_0000296 denotes blood

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T26 0-304 Sentence denotes The IVIG lots were manufactured from plasma either donated by plasmapheresis (source) or recovered from whole-blood donations (recovered), in the United States (Gammagard Liquid; Baxter Healthcare Corp.; n = 30) or central Europe, that is Austria, Germany, and Czech Republic (KIOVIG; Baxter AG; n = 24).